A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer - Schmitz-Winnenthal, Friedrich Hubertus; Hohmann, Nicolas; Schmidt, Thomas; Podola, Lilli; Friedrich, Tobias; Lubenau, Heinz; Springer, Marco; Wieckowski, Sébastien; Breiner, Klaus M.; Mikus, Gerd; Büchler, Markus W.; Keller, Anne-Valérie; et al. (OncoImmunology, 2018)
Published online: 16 Jan 2018